Downregulation of miR-335 exhibited an oncogenic effect via promoting KDM3A/YAP1 networks in clear cell renal cell carcinoma
Open Access
- 23 April 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Gene Therapy
- Vol. 29 (5), 573-584
- https://doi.org/10.1038/s41417-021-00335-3
Abstract
Clear cell renal cell carcinoma (ccRCC) is the most common type of renal cancer affecting many people worldwide. Although the 5-year survival rate is 65% in localized disease, after metastasis, the survival rate is <10%. Emerging evidence has shown that microRNAs (miRNAs) play a crucial regulatory role in the progression of ccRCC. Here, we show that miR-335, an anti-onco-miRNA, is downregulation in tumor tissue and inhibited ccRCC cell proliferation, invasion, and migration. Our studies further identify the H3K9me1/2 histone demethylase KDM3A as a new miR-335-regulated gene. We show that KDM3A is overexpressed in ccRCC, and its upregulation contributes to the carcinogenesis and metastasis of ccRCC. Moreover, with the overexpression of KDM3A, YAP1 was increased and identified as a direct downstream target of KDM3A. Enrichment of KDM3A demethylase on YAP1 promoter was confirmed by CHIP-qPCR and YAP1 was also found involved in the cell growth and metastasis inhibitory of miR-335. Together, our study establishes a new miR-335/KDM3A/YAP1 regulation axis, which provided new insight and potential targeting of the metastasized ccRCC.Keywords
Funding Information
- China Postdoctoral Science Foundation (2020M682800)
This publication has 44 references indexed in Scilit:
- miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 ExpressionClinical Cancer Research, 2014
- starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq dataNucleic Acids Research, 2013
- Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylasesCarcinogenesis: Integrative Cancer Research, 2013
- Stage-dependent differential expression of microRNAs in colorectal cancer: potential role as markers of metastatic diseaseClinical & Experimental Metastasis, 2011
- The JmjC domain‐containing histone demethylase KDM3A is a positive regulator of the G1/S transition in cancer cells via transcriptional regulation of the HOXA1 geneInternational Journal of Cancer, 2011
- Yes‐associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in miceJournal of Hepatology, 2011
- Genome‐wide microRNA expression profiling in renal cell carcinoma: significant down‐regulation of miR‐141 and miR‐200cThe Journal of Pathology, 2008
- Micro-RNA profiling in kidney and bladder cancersUrologic Oncology, 2007
- The Hippo Pathway in Human Upper Gastrointestinal Dysplasia and Carcinoma: A Novel Oncogenic PathwayJournal of Gastrointestinal Cancer, 2007
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006